Examining Recent Advances in Understanding and Treatment of Dry Eye Disease: An Eye on the Pharmacist's Role

,
Pharmacy Times, September 2015 Specialty Pharmacy, Volume 81, Issue 9

This Continuing Education activity is supported by an educational grant from Alcon, Inc.

Faculty

Clark Kebodeaux, PharmD, BCACP

Assistant Professor of Pharmacy Practice

St. Louis College of Pharmacy

St. Louis, Missouri

Shared Faculty, Walgreens Pharmacy

Jamie Shelly, PharmD

Assistant Professor of Pharmacy Practice

St. Louis College of Pharmacy

St. Louis, Missouri

Wellness Pharmacist-Shared Faculty

Shop ‘n Save Pharmacies

Educational Objectives

After completing this continuing education program, the participant will be able to:

  • Examine the pathophysiology of dry eye disease (DED).
  • Explain the diagnostic challenges of DED.
  • Determine the causes of DED, as well as its clinical and quality of life impact.
  • Illustrate nonpharmacologic and pharmacologic therapies based on the severity of DED.
  • Analyze implications for the pharmacist in regard to providing patient education on risk factors, prevention, and management of DED.

Target audience: Pharmacists

Type of activity: Application

Release date: September 7, 2015

Expiration date: September 7, 2016

Estimated time to complete activity: 1.5 hours

Fee: Free

Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEUs) under the ACPE universal activity number 0290-0000-15-096-H01-P. The activity is available for CE credit through September 7, 2016.